KB
Kostas Biliouris Oppenheimer Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
15
Avg Return
Past Year
Past Year
14%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
61.1%
Neutral
38.9%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Initiated
| $15 |
169%
upside
| 1 | -12% |
0
%
| 25 Feb ‘26 13 days ago |
|
|
|
Outperform
Upgraded
| $22 |
79%
upside
| 1 | +15% |
0
%
| 28 Jan ‘26 1 month ago |
|
|
|
Outperform
Maintained
| $62 |
138%
upside
| 1 | -8.8% |
0
%
| 10 Dec ‘25 3 months ago |
|
|
|
Outperform
Upgraded
| $50 |
183%
upside
| 5 | +1.2% |
0
%
| 22 Sep ‘25 5 months ago |
|
|
|
Market Perform
Downgraded
| $48 | – | 1 | – |
–
| 15 Sep ‘25 5 months ago |
|
|
|
Outperform
Maintained
| $470 |
45%
upside
| 2 | +8% |
0
%
| 8 Sep ‘25 6 months ago |
|
|
|
Outperform
Upgraded
| $70 |
7%
downside
| 1 | +31% |
0
%
| 3 Sep ‘25 6 months ago |
|
|
|
Market Perform
Downgraded
| $4 |
205%
upside
| 1 | – |
–
| 8 Jul ‘25 8 months ago |
|
|
|
Market Perform
Downgraded
| $13.50 |
21%
upside
| 1 | – |
–
| 27 Jun ‘25 8 months ago |
|
|
|
Outperform
Maintained
| $8 |
57%
upside
| 2 | +24% |
0
%
| 28 May ‘25 9 months ago |
|
|
|
Outperform
Initiated
| $72 | – | 1 | +146% |
0
%
| 12 Mar ‘25 1 year ago |
|
|
|
Outperform
Initiated
| $50 |
183%
upside
| 1 | +47% |
0
%
| 12 Mar ‘25 1 year ago |
|